Fusarium Infections in Immunocompromised Patients

By M. Nucci, E. Anaissie. Clinical Microbiology Reviews, 2007

938 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. (2014, background): “Mortality from this infection remains high, although new azole antifungal agents appear promising [227].”
Histopathologic Diagnosis of Fungal Infections in the 21st Century (2011, background): “It is important to make organism-specific diagnoses of these molds because some Fusarium species and Scedosporium frequently demonstrate resistance to azoles and echinocandins, thus requiring combination therapy (36, 113).”
Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. (2014, background): “Mortality from this infection remains high, although new azole antifungal agents appear promising [227].”
The Top 10 fungal pathogens in molecular plant pathology. (2012, background): “Fusarium oxysporum is also an emerging pathogen of humans that can cause invasive infections in immunocompromised patients (Nucci and Anaissie, 2007; O’Donnell et al., 2004).”